跳至主要内容
临床试验/NCT02023320
NCT02023320已完成不适用

A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of Blueberry Dry Powder on Prediabetes

Hiroshima University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Change in fasting plasma glucose from baseline

研究概览

简要总结

The purpose of the present study is to evaluate the effect of blueberry dry powder on glycemic status (fasting plasma glucose, 2h glucose concentration after the oral glucose tolerance test (OGTT), or HbA1c) in subjects with prediabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Fasting plasma glucose 110-125 mg/dL

排除标准

  • •Taking anti-diabetic drugs
  • •Taking drugs or functional food that may affect blood glucose level
  • •Fruit allergy
  • •Pregnant or nursing a child
  • •Participation in any clinical trial within 90 days of the commencement of the trial
  • •Renal or hepatic dysfunction
  • •Heart disease

研究组 & 干预措施

Low dose of blueberry dry powder

Experimental

0.5 g blueberry dry powder, twice a day for 12 weeks

干预措施: Low dose of blueberry dry powder (Dietary Supplement)

High dose of blueberry dry powder

Experimental

5.0 g blueberry dry powder, twice a day for 12 weeks

干预措施: High dose of blueberry dry powder (Dietary Supplement)

结局指标

主要结局

Change in fasting plasma glucose from baseline

时间窗: Every 6 weeks (Overall 12 weeks)

Change in HbA1c from baseline

时间窗: Weeks 0 and 12

Change in 2h glucose concentration after the oral glucose tolerance test (OGTT) from baseline

时间窗: Weeks 0 and 12

次要结局

  • Change in serum C-peptide from baseline(Weeks 0 and 12)
  • Change in glycoalbumin from baseline(Every 6 weeks (Overall 12 weeks))
  • Change in fasting insulin from baseline(Weeks 0 and 12)
  • Change in homeostasis model assessment-insulin resistance (HOMA-R) from baseline(Weeks 0 and 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fumiko Higashikawa

Associate Professor

Hiroshima University

研究点 (1)

Loading locations...

相似试验